Nature Communications (Jan 2020)

Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism

  • Megan M. Weivoda,
  • Chee Kian Chew,
  • David G. Monroe,
  • Joshua N. Farr,
  • Elizabeth J. Atkinson,
  • Jennifer R. Geske,
  • Brittany Eckhardt,
  • Brianne Thicke,
  • Ming Ruan,
  • Amanda J. Tweed,
  • Louise K. McCready,
  • Robert A. Rizza,
  • Aleksey Matveyenko,
  • Moustapha Kassem,
  • Thomas Levin Andersen,
  • Adrian Vella,
  • Matthew T. Drake,
  • Bart L. Clarke,
  • Merry Jo Oursler,
  • Sundeep Khosla

DOI
https://doi.org/10.1038/s41467-019-14003-6
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 13

Abstract

Read online

Anti-resorptive bone therapies also inhibit bone formation, as osteoclasts secrete factors that stimulate bone formation by osteoblasts. Here, the authors identify osteoclast-secreted factors that couple bone resorption to bone formation in healthy subjects, and show that osteoclast-derived DPP4 may be a factor coupling bone resorption to energy metabolism.